Figures & data
Table I. A summary of the effects of ghrelin (original reports or reviews with further details are indicated in brackets).
Table II. Transgenic and knockout models for ghrelin and GHS‐R.
Table III. Summary of the findings of studies published between January 2005 and July 2006 with reference to the subject of bariatric surgery and its effects on ghrelin levels. (For previous studies, refer to Citation205).
Korbonits M., Goldstone A. P., Gueorguiev M., Grossman A. B. Ghrelin—a hormone with multiple functions. Front Neuroendocrinol 2004; 25: 27–68 Tena‐Sempere M. Exploring the role of ghrelin as novel regulator of gonadal function. Growth Horm IGF Res 2005; 15: 83–8 Hosoda H., Kojima M., Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 2006; 100: 398–410 Arvat E., Maccario M., Di Vito L., Broglio F., Benso A., Gottero C., et al. Endocrine activities of ghrelin, a natural GH secretagogue, in humans: comparison and interactions with hexarelin, a non natural peptidyl GHS, and GH‐releasing hormone. J Clin Endocrinol Metab 2001; 86: 1169–74 Tschöp M., Smiley D. L., Heiman M. L. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908–13 Tebbe J. J., Mronga S., Tebbe C. G., Ortmann E., Arnold R., Schafer M. K. Ghrelin‐induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1‐ and corticotrophin‐releasing factor 1 receptor activation. J Neuroendocrinol 2005; 17: 570–6 Gauna C., Delhanty P. J., Hofland L. J., Janssen J. A., Broglio F., Ross R. J., et al. Ghrelin stimulates, whereas des‐octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J Clin Endocrinol Metab 2005; 90: 1055–60 Muccioli G., Pons N., Ghe C., Catapano F., Granata R., Ghigo E. Ghrelin and des‐acyl ghrelin both inhibit isoproterenol‐induced lipolysis in rat adipocytes via a non‐type 1a growth hormone secretagogue receptor. Eur J Pharmacol 2004; 498: 27–35 Cao J. M., Ong H., Chen C. Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends Endocrinol Metab 2006; 17: 13–18 Henriques‐Coelho T., Roncon‐Albuquerque J. R., Lourenco A. P., Baptista M. J., Oliveira S. M., Brandao‐Nogueira A., et al. Ghrelin reverses molecular, structural and hemodynamic alterations of the right ventricle in pulmonary hypertension. Rev Port Cardiol 2006; 25: 55–63 Tesauro M., Schinzari F., Iantorno M., Rizza S., Melina D., Lauro D., et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 2005; 112: 2986–92 Rudd J. A., Ngan M. P., Wai M. K., King A. G., Witherington J., Andrews P. L., et al. Anti‐emetic activity of ghrelin in ferrets exposed to the cytotoxic anti‐cancer agent cisplatin. Neurosci Lett 2006; 392: 79–83 Brunetti L., Recinella L., Orlando G., Michelotto B., Di Nisio C., Vacca M. Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur J Pharmacol 2002; 454: 189–92 Dixit V. D., Taub D. D. Ghrelin and immunity: A young player in an old field. Exp Gerontol 2005; 40: 900–10 Yada T., Kaiya H., Mutoh K., Azuma T., Hyodo S., Kangawa K. Ghrelin stimulates phagocytosis and superoxide production in fish leukocytes. J Endocrinol 2006; 189: 57–65 Takeda R., Nishimatsu H., Suzuki E., Satonaka H., Nagata D., Oba S., et al. Ghrelin improves renal function in mice with ischemic acute renal failure. J Am Soc Nephrol 2006; 17: 113–21 Halem H. A., Taylor J. E., Dong J. Z., Shen Y., Datta R., Abizaid A., et al. A novel growth hormone secretagogue‐1a receptor antagonist that blocks ghrelin‐induced growth hormone secretion but induces increased body weight gain. Neuroendocrinol 2005; 81: 339–49 Konturek P. C., Brzozowski T., Pajdo R., Nikiforuk A., Kwiecien S., Harsch I., et al. Ghrelin‐a new gastroprotective factor in gastric mucosa. J Physiol Pharmacol 2004; 55: 325–36 Granado M., Priego T., Martin A. I., Villanua M. A., Lopez‐Calderon A. Anti‐inflammatory effect of the ghrelin agonist growth hormone‐releasing peptide‐2 (GHRP‐2) in arthritic rats. Am J Physiol Endocrinol Metab 2005; 288: E486–92 Wu R., Dong W., Zhou M., Cui X., Hank S. H., Wang P. Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin‐1. Cardiovasc Res 2005; 68: 318–26 Heijboer A. C., van den Hoek A. M., Parlevliet E. T., Havekes L. M., Romijn J. A., Pijl H., et al. Ghrelin differentially affects hepatic and peripheral insulin sensitivity in mice. Diabetologia 2006; 49: 732–8 Fukushima N., Hanada R., Teranishi H., Fukue Y., Tachibana T., Ishikawa H., et al. Ghrelin directly regulates bone formation. J Bone Miner Res 2005; 20: 790–8 Caminos J. E., Gualillo O., Lago F., Otero M., Blanco M., Gallego R., et al. The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes. Endocrinology 2005; 146: 1285–92 Matsuda K., Miura T., Kaiya H., Maruyama K., Uchiyama M., Kangawa K., et al. Stimulatory effect of n‐octanoylated ghrelin on locomotor activity in the goldfish, Carassius auratus. Peptides 2006; 27: 1335–40 Jaszberenyi M., Bujdoso E., Bagosi Z., Telegdy G. Mediation of the behavioral, endocrine and thermoregulatory actions of ghrelin. Horm Behav 2006; 50: 266–73 Tang‐Christensen M., Vrang N., Ortmann S., Bidlingmaier M., Horvath T. L., Tschop M. Central Administration of Ghrelin and Agouti‐Related Protein (83‐132) Increases Food Intake and Decreases Spontaneous Locomotor Activity in Rats. Endocrinology 2004; 145: 4645–52 Diano S., Farr S. A., Benoit S. C., McNay E. C., da Silva I., Horvath B., et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006; 9: 381–8 Sun Y., Ahmed S., Smith R. G. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 2003; 23: 7973–81 Wortley K. E., Anderson K. D., Garcia K., Murray J. D., Malinova L., Liu R., et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 2004; 101: 8227–32 Wortley K. E., Del Rincon J. P., Murray J. D., Garcia K., Iida K., Thorner M. O., et al. Absence of ghrelin protects against early‐onset obesity. J Clin Invest 2005; 115: 3573–8 De Smet B., Depoortere I., Moechars D., Swennen Q., Moreaux B., Cryns K., et al. Energy homeostasis and gastric emptying in ghrelin knockout mice. J Pharmacol Exp Ther 2006; 316: 431–9 Shearman L. P., Wang S. P., Helmling S., Stribling D. S., Mazur P., Ge L., et al. Ghrelin neutralization by a ribonucleic acid‐SPM ameliorates obesity in diet‐induced obese mice. Endocrinology 2006; 147: 1517–26 Vizcarra J. A., Kirby J. D., Kim S. K., Galyean M. L. Active immunization against ghrelin decreases weight gain and alters plasma concentrations of growth hormone in growing pigs. Domest Anim Endocrinol 2006 Jun 8, [Epub ahead of print] Ariyasu H., Takaya K., Iwakura H., Hosoda H., Akamizu T., Arai Y., et al. Transgenic mice overexpressing des‐acyl ghrelin show small phenotype. Endocrinology 2005; 146: 355–64 Wei W., Qi X., Reed J., Ceci J., Wang H. Q., Wang G., et al. Effect of chronic hyperghrelinemia on ingestive action of ghrelin. Amer J Physiol Regul Integr Comp Physiol 2006; 290: R803–08 Sun Y., Asnicar M., Saha P. K., Chan L., Smith R. G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 2006; 3: 379–86 Sun Y., Wang P., Zheng H., Smith R. G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 2004; 101: 4679–84 Zigman J. M., Jones J. E., Lee C. E., Saper C. B., Elmquist J. K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 2006; 494: 528–48 Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M. A., et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003; 52: 947–52 Shuto Y., Shibasaki T., Otagiri A., Kuriyama H., Ohata H., Tamura H., et al. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 2002; 109: 1429–36 Aylwin S. J. Gastrointestinal surgery and gut hormones. Current Opinion In Endocrinology and Diabetes 2005; 12: 89–98 Langer F. B., Reza Hoda M. A., Bohdjalian A., Felberbauer F. X., Zacherl J., Wenzl E., et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005; 15: 1024–9 Borg C. M., Le Roux C. W., Ghatei M. A., Bloom S. R., Patel A. G., Aylwin S. J. Progressive rise in gut hormone levels after Roux‐en‐Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 2006; 93: 210–15 Mariani L. M., Fusco A., Turriziani M., Veneziani A., Marini M. A., de Lorenzo A., et al. Transient increase of plasma ghrelin after laparoscopic adjustable gastric banding in morbid obesity. Horm Metab Res 2005; 37: 242–5 Foschi D., Corsi F., Rizzi A., Asti E., Carsenzuola V., Vago T., et al. Vertical banded gastroplasty modifies plasma ghrelin secretion in obese patients. Obes Surg 2005; 15: 1129–32 Suzuki S., Ramos E. J., Goncalves C. G., Chen C., Meguid M. M. Changes in GI hormones and their effect on gastric emptying and transit times after Roux‐en‐Y gastric bypass in rat model. Surgery 2005; 138: 283–90 Le Roux C. W., Aylwin S. J., Batterham R. L., Borg C. M., Coyle F., Prasad V., et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006; 243: 108–14 Stratis C., Alexandrides T., Vagenas K., Kalfarentzos F. Ghrelin and peptide YY levels after a variant of biliopancreatic diversion with Roux‐en‐Y gastric bypass versus after colectomy: a prospective comparative study. Obes Surg 2006; 16: 752–8 Stylopoulos N., Davis P., Pettit J. D., Rattner D. W., Kaplan L. M. Changes in serum ghrelin predict weight loss after Roux‐en‐Y gastric bypass in rats. Surg Endosc 2005; 19: 942–6 Lin E., Gletsu N., Fugate K., McClusky D., Gu L. H., Zhu J. L., et al. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg 2004; 139: 780–4 Korner J., Bessler M., Cirilo L. J., Conwell I. M., Daud A., Restuccia N. L., et al. Effects of Roux‐en‐Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab 2005; 90: 359–65 Ram E., Vishne T., Diker D., Gal‐Ad I., Maayan R., Lerner I., et al. Impact of gastric banding on plasma ghrelin, growth hormone, cortisol, DHEA and DHEA‐S levels. Obes Surg 2005; 15: 1118–23